Report cover image

Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial

Publisher Coherent Market Insights
Published Oct 09, 2023
Length 150 Pages
SKU # CMI18299732

Description

Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial) Biotechnology, Agricultural Biotechnology, Others, By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)


Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial) Biotechnology, Agricultural Biotechnology, Others, By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)


Red biotechnology, also known as medical biotechnology, is a subsector of biotechnology that focuses on medical and healthcare applications. It involves the use of biotechnology techniques to develop new drugs, therapies, and medical technologies for the treatment and prevention of diseases.

Market Dynamics:

Red biotechnology market is driven by several factors. These include the increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, personalized medicine, and gene therapies are also key drivers. Additionally, government investments, regulatory support, and growing private sector interest contribute to the growth of red biotechnology, which aims to develop innovative medical treatments and therapies.

However, high costs associated with biologics drug development is expected to restrain the market growth.

Key features of the study:
  • This report provides in-depth analysis of the global red biotechnology market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global red biotechnology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co., AbbVie, GlaxoSmithKline, AstraZeneca, Eli Lilly, Novo Nordisk, Bayer, Bristol-Myers Squibb, Teva Pharmaceutical, Takeda Pharmaceutical, Boehringer Ingelheim, and Astellas Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global red biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global red biotechnology market
Red Biotechnology Market Detailed Segmentation:
  • By Product Type
  • Biopharmaceuticals
  • Biosimilars
  • Gene Therapy
  • Tissue Engineering
  • Cell Therapy
  • By Application
  • Drug Discovery & Development
  • Animal Biotechnology
  • Environmental Biotechnology
  • Medical Biotechnology
  • Industrial Biotechnology
  • Agricultural Biotechnology
  • Others
  • By End User
  • Pharmaceutical & Biopharmaceutical Companies
  • Research Institutes
  • Biotechnology Industry
  • Hospitals & Diagnostic Centers
  • Academic Institutions
  • Top companies in Red Biotechnology Market
  • Amgen
  • Gilead Sciences
  • Biogen
  • Pfizer
  • Novartis
  • Roche
  • Johnson & Johnson
  • Sanofi
  • Merck & Co.
  • AbbVie
  • GlaxoSmithKline
  • AstraZeneca
  • Eli Lilly
  • Novo Nordisk
  • Bayer
  • Bristol-Myers Squibb
  • Teva Pharmaceutical
  • Takeda Pharmaceutical
  • Boehringer Ingelheim
  • Astellas Pharma

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Red Biotechnology, By Product Type
Market Red Biotechnology, By Application
Market Red Biotechnology, By End User
Market Red Biotechnology, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing Prevalence of Chronic Diseases
Pricing Pressures on Biologics
Biotech Applications in Agriculture
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Red Biotechnology Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Red Biotechnology Market , By Product Type, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Biopharmaceuticals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Biosimilars
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Tissue Engineering
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Red Biotechnology Market , By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Drug Discovery & Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Animal Biotechnology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Environmental Biotechnology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Medical Biotechnology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Industrial Biotechnology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Agricultural Biotechnology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Red Biotechnology Market , By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Pharmaceutical & Biopharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Biotechnology Industry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Hospitals & Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Academic Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Red Biotechnology Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
9. Competitive Landscape
Amgen
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Gilead Sciences
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Biogen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Roche
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Others
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Red Biotechnology Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us